Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is an oncology-focused biopharmaceutical company focused on the discovery, development and commercialization of novel medicines. Learn more
Launch date
Employees
Market cap
€86.6m
Enterprise valuation
€126m (Public information from Sep 2024)
Share price
$0.737 KPTI
Newton Massachusetts (HQ)
Authorizing premium user...